HLA antigens in patients with interferon-α-induced autoimmune thyroid disorders in chronic hepatitis C

Journal of Hepatology

Volumn 30, Issue 5, 1999, Pages 794-800

  Kakizaki, Satoru ^a   Takagi, Hitoshi ^a   Murakami, Masami ^a   Takayama, Hisashi ^a   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Autoimmune thyroid disorders; Hepatitis C; HLA; Interferon

Indexed keywords

ALPHA INTERFERON; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG SAFETY; FEMALE; HEPATITIS C; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; THYROID DISEASE;

EID: 0032999613     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80131-7     Document Type: Article

References (24)

1. Conlon KC, Urba WJ, Smith JW, Steis RG, Longo DL, Clark JW. Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer. 65:1990;2237-2242.
2. Lisker-Melman M, Di Bisceglie AM, Usala SJ, Weintraub B, Murrary LM, Hoofnagle JH. Development of thyroid disease during therapy of chronic viral hepatitis with interferon alpha. Gastroenterology. 102:1992;2155-2160.
3. Bacq Y, Sapey T, Gruel Y, Fimbel B, Degenne D, Barin F, et al. Exacerbation of an autoimmune thrombocytopenic purpura during treatment with interferon alpha in a woman with chronic viral hepatitis C. Gastroenterol Clin Biol. 20:1996;303-306.
4. Okanoue T, Sakamoto S, Itoh Y, Minami M, Yasui K, Sakamoto M, et al. Side effects of high-dose interferon for chronic hepatitis C. J Hepatol. 25:1996;283-291.
5. Dusheiko G. Side-effects of alpha interferon in chronic hepatitis C. Hepatology. 26:1997;112S-121S.
6. Sachithanandan S, Clarke G, Crowe J, Fielding JF. Interferon-associated thyroid dysfunction in anti-D-related chronic hepatitis C. J Interferon Cytokine Res. 17:1997;409-411.
7. Marazuela M, Garcia-Buey L, Gonzalez-Fernandez B, Gracia-Monzon C, Arranz A, Borque MJ, et al. Thyroid autoimmune disorders in patients with chronic hepatitis C before and after interferon-α therapy. Clin Endocrinol (Oxf). 44:1996;635-642.
8. Watanabe U, Hashimoto E, Hisamitsu T, Obata H, Hayashi N. The risk factor for development of thyroid disease during interferon-α therapy for chronic hepatitis C. Am J Gastroenterol. 89:1994;399-400.
9. Deutsch M, Dourakis S, Manesis EK, Gioustozi A, Hess G, Horsch A, et al. Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alpha therapy. Hepatology. 26:1997;206-210.
10. Nagayama Y, Ohta K, Tsuruta M, Takeshita A, Kimura H, Hamasaki K, et al. Exacerbation of thyroid autoimmunity by interferon-α treatment in patients with chronic viral hepatitis: our study and review of the literature. Endocr J. 41:1994;565-572.
11. Takagi H, Takehara K, Shimoda R, Kakizaki S, Takayama H, Abe T, et al. Prediction of effect of interferon on chronic hepatitis C. Dig Dis Sci. 42:1997;2270-2276.
12. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers; application to clinical surveys and tracing infectious sources. J Gen Virol. 73:1992;673-679.
13. Terasaki PI, Bernoco D, Park MS, Ozturk G, Iwaki Y. Microdroplet testing for HLA-A, -B, -C, and -D antigens. Am J Clin Pathol. 69:1978;103-120.
14. Hashimoto M, Kinoshita T, Yamasaki M, Tanaka H, Imanishi T, Ihara H, et al. Gene frequencies and haplotypic associations within the HLA region in 916 unrelated Japanese individuals. Tissue Antigens. 44:1994;166-173.
15. Kuzushita N, Hayashi N, Moribe T, Katayama K, Kanto T, Nakatani S, et al. Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus. Hepatology. 27:1998;240-244.
16. Baudin E, Marcellin P, Pouteau M, Colas-Linhart N, Le-Floch JP, Lemmonier C, et al. Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C. Clin Endocrinol (Oxf). 39:1993;657-661.
17. Martin-Vivaldi R, Nogueras F, Quintero D, Espinosa MD, Lopez-de-Hierro M, Suarez JF, et al. Thyroid dysfunction in patients with chronic hepatitis C pre and post treatment with interferon. Rev Esp Enferm Dig. 88:1996;480-484.
18. Dong RP, Kimura A, Okubo R, Shinagawa H, Tamai H, Nishimura Y, et al. HLA-A and DPB1 loci confer susceptibility to Grave's disease. Hum Immunol. 35:1992;165-172.
19. Wan XL, Kimura A, Dong RP, Honda K, Tamai H, Sasazuki T. HLA-A and DRB4 genes in controlling the susceptibility to Hashimoto's thyroiditis. Hum Immunol. 42:1995;131-136.
20. Naito S, Sasaki H, Arakawa K. Japanese Graves' disease association with HLA-Bw46. Endocrinol Jpn. 34:1987;685-688.
21. Inoue D, Sato K, Enomoto T, Sugawa H, Maeda M, Inoko H, et al. Correlation of HLA types and clinical findings in Japanese patients with hyperthyroid Graves' disease: evidence indicating the existence of four subpopulations. Clin Endocrinol. 36:1992;75-82.
22. de-Bruin TW, Bolk JH, Bussemaker JK, Stijnen T, Schreuder GM, de-Vries RR, et al. Graves' disease: immunological and immunogenetic indicators of relapse. Br Med J Clin Res Ed. 296:1988;1292-1295.
23. Czaja AJ, Carpenter H, Santrach PJ, Moore SB. DR human leukocyte antigens and disease severity in chronic hepatitis C. J Hepatol. 24:1996;663-667.
24. Vitte RL, Fortier C, Richardet JP, Grimbert S, Trinchet JC, Beaugrand M, et al. HLA antigens in patients with chronic hepatitis C. Tissue Antigens. 45:1995;356-361.